Skip to content

Rejuvel Bio-Sciences, Inc.: 10-Q filed 2014-08-14

What Rejuvel Bio-Sciences, Inc. reported in its quarterly report filed 2014-08-14 (fiscal Q2 2014): 28 published measures, 89 facts as tagged in accession 0001469709-14-000336.

This filing

Form
10-Q (quarterly report)
Filed
2014-08-14
Fiscal period
fiscal Q2 2014
Accession
0001469709-14-000336 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Rejuvel Bio-Sciences, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-06-30289,972USD
At 2013-12-31105,973USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-06-301,435,116USD
At 2013-12-311,207,335USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-06-30-1,145,144USD
At 2013-12-31-1,101,362USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-06-30172,634USD
At 2013-12-314,891USD
At 2013-06-301,298USD
At 2012-12-31120,697USD
At 2009-10-150USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,711,412USD91
2014-01-01 to 2014-06-30-676,631USD181
2009-10-16 to 2014-06-30-2,481,270USD1719
2013-04-01 to 2013-06-30-139,128USD91
2013-01-01 to 2013-06-30-327,562USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-244,399USD181
2009-10-16 to 2014-06-30-1,455,716USD1719
2013-01-01 to 2013-06-30-144,482USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-04-01 to 2014-06-3043,056USD91
2014-01-01 to 2014-06-3045,324USD181
2009-10-16 to 2014-06-30106,362USD1719
2013-04-01 to 2013-06-3021,481USD91
2013-01-01 to 2013-06-3031,528USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-06-30413,960USD181
2009-10-16 to 2014-06-301,663,891USD1719
2013-01-01 to 2013-06-3025,083USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-1,818USD181
2009-10-16 to 2014-06-30-35,541USD1719
2013-01-01 to 2013-06-300USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-06-30-2,481,270USD
At 2013-12-31-1,804,909USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-04-01 to 2014-06-30118,573,786shares91
2014-01-01 to 2014-06-30118,128,337shares181
2013-04-01 to 2013-06-30117,248,000shares91
2013-01-01 to 2013-06-30117,248,000shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-04-01 to 2014-06-30119,795,413shares91
2014-01-01 to 2014-06-30118,128,337shares181
2013-04-01 to 2013-06-30117,248,000shares91
2013-01-01 to 2013-06-30117,248,000shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-04-01 to 2014-06-300.01USD/shares91
2014-01-01 to 2014-06-30-0.01USD/shares181
2013-04-01 to 2013-06-300USD/shares91
2013-01-01 to 2013-06-300USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-04-01 to 2014-06-300.01USD/shares91
2014-01-01 to 2014-06-30-0.01USD/shares181
2013-04-01 to 2013-06-300USD/shares91
2013-01-01 to 2013-06-300USD/shares181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-125,321USD91
2014-01-01 to 2014-06-30-254,701USD181
2009-10-16 to 2014-06-30-1,717,456USD1719
2013-04-01 to 2013-06-30-129,371USD91
2013-01-01 to 2013-06-30-263,431USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-06-30269,362USD
At 2013-12-3184,662USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-12-31197,452USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-06-301,435,116USD
At 2013-12-311,207,335USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-06-3087,819USD
At 2013-12-3170,862USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-04-01 to 2014-06-3037,082USD91
2014-01-01 to 2014-06-3036,430USD181
2009-10-16 to 2014-06-3066,169USD1719
2013-04-01 to 2013-06-3019,672USD91
2013-01-01 to 2013-06-3024,270USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2014-04-01 to 2014-06-305,974USD91
2014-01-01 to 2014-06-308,894USD181
2009-10-16 to 2014-06-3040,193USD1719
2013-04-01 to 2013-06-301,809USD91
2013-01-01 to 2013-06-307,258USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-06-30118,581,149shares
At 2013-12-31117,348,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-06-301,217,544USD
At 2013-12-31586,199USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-06-30-14,747USD
At 2013-12-31-12,282USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-06-301,886USD
At 2013-12-311,940USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-04-01 to 2014-06-30162,403USD91
2014-01-01 to 2014-06-30291,131USD181
2009-10-16 to 2014-06-301,783,625USD1719
2013-04-01 to 2013-06-30149,043USD91
2013-01-01 to 2013-06-30287,701USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-06-30315,500USD181
2009-10-16 to 2014-06-30824,750USD1719
2013-01-01 to 2013-06-300USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-16,957USD181
2009-10-16 to 2014-06-30-87,819USD1719
2013-01-01 to 2013-06-305,138USD181

Inspect the source

Entity
Rejuvel Bio-Sciences, Inc. / CIK 0001481427
Captured
SEC response SHA-256
4a018d6151ebf80d4c67ed9e7073ee9a3240164f46be0f2dea7bcfa00e98d7fe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001481427.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))